2022年第18期
共21篇·Review Article
1. Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy 2143-2156页
3. Tc17 cells in autoimmune diseases 2167-2177页
4. Application of synthetic biology in bladder cancer 2178-2187页
作者:Ding MengtingLin JiaxingQin CaipengWei PingTian JiaheLin TianxinXu Tao
·Perspective
5. Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis 2188-2190页
·Original Article
6. Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII 2191-2199页
作者:Gui YinliBai WeiXu JianDuan XinwangZhan FengZhao ChenJiang ZhenyuLi ZhijunWu LijunLiu ShengyunYang MinWei WeiWang ZiqianZhao JiuliangWang QianLeng XiaomeiTian XinpingLi MengtaoZhao YanZeng XiaofengCSTAR co-authors
7. Efficacy, safety, and cost-effectiveness of triple therapy in preventing relapse in rheumatoid arthritis: A randomized controlled trial (ESCoRT study) 2200-2209页
作者:Zhao JuanZhou WeiWu YangfengYan XiaoyanYang LiZhang Zhuoli
8. Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients 2210-2217页
作者:Jiang NanLi QinLi HongbinFang YongfeiWu LijunDuan XinwangXu JianZhao ChengJiang ZhenyuWang YanhongWang QianLeng XiaomeiLi MengtaoTian XinpingZeng XiaofengCREDIT Co-Authors
9. Comprehensive analysis identifies as a critical prognostic prediction gene in breast cancer 2218-2231页
10. Lipopolysaccharide induced intestinal epithelial injury: a novel organoids-based model for sepsis in vitro 2232-2239页
作者:Huang SisiZhang ShengChen LiminPan XiaojunWen ZhenliangChen YizhuZhang LidiLiu JiaoChen Dechang
·Technical Notes
11. Sleeve gastrectomy plus uncut jejunojejunal bypass for the treatment of obesity and type 2 diabetes 2240-2241页
·Clinical Observation
12. Percutaneous vertebroplasty combined with chemotherapy in the treatment of multiple myeloma patients with vertebral compression fractures 2242-2244页
作者:Zhang YangZheng HuayongWang FeiZhang LizhiZhang YuanLiu XiumeiZhang ZhichengLi Fang
·Correspondence
13. Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study 2245-2247页
作者:Bai WeiLi MengtaoZhou ShuangPeng LiyingZhao JiuliangTian XinpingWang QianLeng XiaomeiZhang ShangzhuWang YanhongZhao YanZeng Xiaofeng
14. Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis 2248-2250页
作者:Zhang SiCai LinZhang HengZhao ZhengLiu XiaoyangZhao YanZhang Jianzhong
15. Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored 2251-2252页
作者:Huang CanHu ChaojunZhao JiuliangWang QianTian XinpingLi MengtaoZeng Xiaofeng